Tylvalosin is primarily used in veterinary medicine as an antimicrobial agent for the treatment of bacterial infections in swine and poultry. It is effective against respiratory diseases caused by pathogens such as Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae in pigs, helping to reduce lung lesions and improve growth performance. In poultry, it is used to manage diseases like air sacculitis and chronic respiratory disease associated with Mycoplasma gallisepticum and Mycoplasma synoviae. Tylvalosin also shows anti-inflammatory properties at sub-antimicrobial doses, which can help modulate the host immune response and reduce tissue damage during infection. Its targeted activity and favorable safety profile make it a valuable tool in food-producing animals, with minimal impact on the environment and low risk of residue accumulation when used according to guidelines.